OR WAIT 15 SECS
© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
February 24, 2021
In a systematic review, investigators aim to understand the mechanisms for comorbid bipolar disorder and migraine, as well as therapeutic targets.
February 17, 2021
In addition to reducing the frequency of migraine days, galcanezumab may also potentially decrease disabling non-pain symptoms of migraine on days when migraine is present.
February 10, 2021
The relatively new biologic therapies for migraine demonstrated low immunogenicity rates and rare adverse events.
February 09, 2021
Pharmacists are well positioned to support the care of patients with migraines and offer advice on treatments.
January 22, 2021
Patients reported more frequent and severe migraines, along with overuse of analgesics.
January 21, 2021
A study observed gaps in migraine knowledge in women’s health care providers. Pharmacists can play a role in provider education on prophylaxis and treatment.
January 15, 2021
Investigators observed that about half of patients treated with rimegepant showed a 50% or greater reduction in how many moderate-to-severe migraine days they experienced per month.
January 14, 2021
Pharmacists can provide education on migraine prophylaxis for better outcomes.
January 06, 2021
Researchers examined the 3 debated strategies for treating medication overuse headache.
January 05, 2021
A poster presented at the ASHP 2020 Midyear Clinical Meeting and Exhibition indicated opportunities for community pharmacists to improve outcomes for patients with migraines.